We are live on ! Find out more
GT

Glenmede Trust Portfolio holdings

AUM $20.4B
This Fund
S&P 500
This Quarter Est. Return
+6.7%
1 Year Est. Return
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$8.42B
AUM Growth
+$395M
Cap. Flow
+$387M
Cap. Flow %
4.59%
Top 10 Hldgs %
13.3%
Holding
2,480
New
199
Increased
650
Reduced
579
Closed
158

Sector Composition

Rank Sector Weight
1 Technology 13.93%
2 Industrials 13.23%
3 Financials 11.33%
4 Healthcare 11.29%
5 Consumer Staples 8.23%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
IRBT
976
DELISTED
iRobot
IRBT
$256K ﹤0.01%
6,811
-3,266
-32% -$117K
ELN
977
DELISTED
ELAN CORP ADS(RP1 ORD4IRISH PN
ELN
$255K ﹤0.01%
16,400
ETR icon
978
Entergy
ETR
$53.1B
$251K ﹤0.01%
7,978
-100
-1% -$3.32K
EXPR
979
DELISTED
Express, Inc.
EXPR
$251K ﹤0.01%
533
+13
+3% +$5.74K
MOLXA
980
DELISTED
MOLEX INC CL-A
MOLXA
$251K ﹤0.01%
6,589
-4,600
-41% -$175K
PSA icon
981
Public Storage
PSA
$60.5B
$250K ﹤0.01%
1,566
-100
-6% -$15.8K
CCC
982
DELISTED
Calgon Carbon Corp
CCC
$249K ﹤0.01%
13,120
SWX icon
983
Southwest Gas
SWX
$6.66B
$248K ﹤0.01%
4,972
SRPT icon
984
Sarepta Therapeutics
SRPT
$1.68B
$247K ﹤0.01%
5,235
+235
+5% +$9.05K
BKLN icon
985
Invesco Senior Loan ETF
BKLN
$6.97B
$246K ﹤0.01%
10,000
-218
-2% -$5.41K
NAB
986
DELISTED
NATL AUSTRALIA BK LTD ADS5
NAB
$246K ﹤0.01%
7,677
WNR
987
DELISTED
Western Refining Inc
WNR
$246K ﹤0.01%
8,207
ANIK icon
988
Anika Therapeutics
ANIK
$200M
$245K ﹤0.01%
10,260
-5,000
-33% -$112K
ISRG icon
989
Intuitive Surgical
ISRG
$128B
$245K ﹤0.01%
5,886
-23,265
-80% -$1.03M
CNMD icon
990
CONMED
CNMD
$1.31B
$244K ﹤0.01%
+7,195
New +$235K
JBL icon
991
Jabil
JBL
$32.6B
$244K ﹤0.01%
11,300
-57,280
-84% -$1.31M
AUQ
992
DELISTED
AURICO GOLD INC COM
AUQ
$244K ﹤0.01%
64,380
+15,480
+32% +$69.5K
TLM
993
DELISTED
TALISMAN ENERGY INC
TLM
$244K ﹤0.01%
21,269
-2,262
-10% -$25.3K
ATI icon
994
ATI
ATI
$26.3B
$243K ﹤0.01%
8,008
-14
-0.2% -$392
FLS icon
995
Flowserve
FLS
$9.29B
$243K ﹤0.01%
3,906
+63
+2% +$3.64K
BG icon
996
Bunge Global
BG
$22.8B
$242K ﹤0.01%
3,200
-79
-2% -$5.98K
MTRN icon
997
Materion
MTRN
$5.03B
$242K ﹤0.01%
7,578
MGLN
998
DELISTED
Magellan Health Services, Inc.
MGLN
$242K ﹤0.01%
+4,045
New +$234K
HIG icon
999
Hartford Financial Services
HIG
$38.4B
$240K ﹤0.01%
7,738
+698
+10% +$21.8K
CLF icon
1000
Cleveland-Cliffs
CLF
$6.99B
$239K ﹤0.01%
11,746
-68
-0.6% -$1.4K

Similar funds

Glenmede Trust's Q3 2013 Portfolio in Review

As of Q3 2013, Glenmede Trust held 2,480 positions worth $8.42B, up 4.9% from $8.03B the previous quarter. Its ten largest holdings account for 13% of the portfolio.

Glenmede Trust deployed $387M of net new capital in Q3 2013, opening 199 new positions and adding to 650 existing holdings. Its largest new stake was WisdomTree Emerging Markets High Dividend Fund: 294,160 shares worth $15.2M.

By sector, the portfolio is most concentrated in Technology at 14% of assets, up from 13% a quarter earlier, followed by Industrials and Financials.

On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $18.5M trimmed.

  • Glenmede Trust's largest Q3 2013 buy was WisdomTree Emerging Markets High Dividend Fund: 294,160 shares worth $15.2M.
  • Glenmede Trust added most to Vanguard FTSE Developed Markets ETF in Q3 2013, an estimated $19.3M increase.
  • Glenmede Trust's biggest Q3 2013 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $18.5M.
  • Glenmede Trust fully exited PacWest Bancorp in Q3 2013, selling an estimated $9.3M.
  • Glenmede Trust's ten largest holdings make up 13% of its $8.42B portfolio in Q3 2013.
  • Glenmede Trust opened 199 new positions and closed 158 in Q3 2013.
  • Glenmede Trust's portfolio value rose 4.9% quarter-over-quarter to $8.42B.

Based on Glenmede Trust's 13F filing for Q3 2013, filed 14 Nov 2013.